Methodist Hospitals Neuroscience Institute

Merrillville, Indiana

Dedicated MS Practice
3 Active TrialsInfusion CenterMedium Practice
2 MS centers statewide · Ranked #1 in Indiana for clinical trials · #1 in Indiana for provider count
What kind of place is this?
Comprehensive Care TeamResearch FocusedInfusion On-Site

You are coming to a dedicated MS center that brings specialty neurology, infusion care, and support services together. You can expect access to experienced clinicians, patient education, and a team-based approach that supports both treatment and day-to-day living with MS. You may need to travel to one of its regional locations for care, since this is a multi-site program.

Facility Profile
Synthesized from this facility's public website and data sources. Not a recommendation or ranking — just a summary to help you orient.
Direct Doctor Access4/5
Support Services5/5
Clinical Trials & Research4/5
Insurance & Navigation Help3/5
Scheduling & Virtual Care3/5

About Methodist Hospitals Neuroscience Institute

This center combines MS specialty care with on-site infusion services, physical therapy, and a support group.

Methodist Hospitals Neuroscience Institute cares for people with multiple sclerosis, NMOSD, MOGAD, autoimmune encephalitis, neurosarcoidosis, transverse myelitis, and other autoimmune-related neurologic conditions. Patients have access to outpatient treatment, advanced neurodiagnostics, an infusion center, physical therapy, patient education, and an MS support group. The program is part of Methodist Hospitals and Methodist Physician Group. If you want a regional MS center with both treatment and support services, this is a strong option to explore.

Methodist Hospitals Neuroscience Institute offers a dedicated Multiple Sclerosis Program in Merrillville for people living with MS and related neurologic conditions. The team provides outpatient care, on-site infusions, physical therapy, patient education, and support groups so you can get care and guidance in one place. You can also connect with a team that includes neurologists, nurse practitioners, and MS-certified support staff.

Featured Care Team Members

William Conte, MD
MS program leader; neurologist
Multiple sclerosis; neuroimmunology
Daksha C. Vyas, MD
Neurology team physician
Neurology
Kristy Darnell, MSN, FNP, CNRN
Neurology nurse practitioner
Neurosurgery and neurology
Mary Hoffman, MSN, FNP-C, CNRN
Neurology nurse practitioner
Neuroscience nursing
William Conte, M.D.
Active MS Prescriber
Richard Cristea, M.D.
High Volume MS Prescriber
Louis Teodori, D.O.
High Volume MS Prescriber
Daksha Vyas, M.D.
Active MS Prescriber

Specialized Programs

Multiple Sclerosis Program
Multiple Sclerosis Patient Stories
MS Support Group
Infusion Center
Experienced Specialists

Services & Treatments

What They Treat
Multiple sclerosisNeuromyelitis optica spectrum disorder (NMOSD)MOG antibody disease (MOGAD)Autoimmune encephalitisNeurosarcoidosisNeuroinfectious diseaseTransverse myelitisNeurologic complications of autoimmune disease
How They Treat It
Multiple sclerosis careOutpatient treatmentInfusion servicesSupport groupsPatient educationPhysical therapyNeurodiagnosticsClinical trial participationLemtradaOcrevusTysabriBriumviSolu MedrolPhysical therapyDry needling therapy
Diagnostics
NeurodiagnosticsAdvanced diagnostic technologies

Research & Clinical Trials

This center is currently involved in 3 clinical trials — ranked #1 in Indiana for active trials

Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis
Sanofi
RECRUITINGPHASE3
FrexalimabTeriflunomidePlacebo infusionPlacebo tabletMRI contrast-enhancing agentsCholestyramineActivated charcoal
Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis
Sanofi
RECRUITINGPHASE3
FrexalimabPlaceboMRI contrast-enhancing agents
Efficacy and Safety of Remibrutinib Compared to Teriflunomide in Participants With Relapsing Multiple Sclerosis (RMS)
Novartis Pharmaceuticals
ACTIVE NOT RECRUITINGPHASE3
RemibrutinibTeriflunomide

Insurance & Access

Contact
200 E 89th Ave, Merrillville, IN 46410
Insurance & Support
Patient Portal
Support Groups

FAQs from Methodist Hospitals Neuroscience Institute

The program treats multiple sclerosis and several related neurologic conditions, including NMOSD, MOGAD, autoimmune encephalitis, neurosarcoidosis, neuroinfectious disease, transverse myelitis, and neurologic complications of autoimmune disease.

Yes. The program has an on-site Infusion Center, and treatments mentioned include Lemtrada, Ocrevus, Tysabri, Briumvi, and Solu Medrol.

Yes. The MS Support Group meets at Southlake Campus on the third Friday of every month.

The team includes William Conte, MD, who leads the MS program, along with Daksha C. Vyas, MD, Kristy Darnell, MSN, FNP, CNRN, and Mary Hoffman, MSN, FNP-C, CNRN.

You can call 219-738-4927 to learn more about the program or make an appointment.

Compare Indiana MS Centers

CenterTypeInfusionVirtualExperience
Methodist Hospitals Neuroscience Institute
Merrillville
Dedicated MS Practice3.8/5
Community Hospital Program3.2/5
Methodist Hospitals Neuroscience Institute
Merrillville • Dedicated MS Practice
Infusion
Virtual
Experience
3.8/5
IU Health Physicians - Fort Wayne - Hope Drive
Fort Wayne • Community Hospital Program
Infusion
Virtual
Experience
3.2/5

Check out the MS Buddy App

Track symptoms, monitor wellness, and stay on top of your MS care. It's free, no ads. How? It's made and supported by MS patients who get their ideas from other MS patients.

Download on the App StoreGet it on Google Play
Call Website